HIMS & HERS HEALTH INC (HIMS) Stock Price, Forecast & Analysis

NYSE:HIMS • US4330001060

16.27 USD
-0.03 (-0.18%)
At close: Feb 17, 2026
16.42 USD
+0.15 (+0.92%)
Pre-Market: 2/18/2026, 6:11:45 AM

HIMS Key Statistics, Chart & Performance

Key Statistics
Market Cap3.70B
Revenue(TTM)2.21B
Net Income(TTM)133.79M
Shares227.65M
Float204.96M
52 Week High70.43
52 Week Low15.63
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)0.54
PE30.13
Fwd PE27.98
Earnings (Next)02-23
IPO2019-09-09
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
HIMS short term performance overview.The bars show the price performance of HIMS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

HIMS long term performance overview.The bars show the price performance of HIMS in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 40 -40 -60

The current stock price of HIMS is 16.27 USD. In the past month the price decreased by -48.15%. In the past year, price decreased by -66.98%.

HIMS & HERS HEALTH INC / HIMS Daily stock chart

HIMS Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
HIMS Full Technical Analysis Report

HIMS Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to HIMS. HIMS has a medium profitability rating, but doesn't score so well on its financial health evaluation.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
HIMS Full Fundamental Analysis Report

HIMS Financial Highlights

Over the last trailing twelve months HIMS reported a non-GAAP Earnings per Share(EPS) of 0.54. The EPS increased by 22.73% compared to the year before.


Industry RankSector Rank
PM (TTM) 6.05%
ROA 5.99%
ROE 23.03%
Debt/Equity 1.67
Chartmill High Growth Momentum
EPS Q2Q%-81.25%
Sales Q2Q%49.16%
EPS 1Y (TTM)22.73%
Revenue 1Y (TTM)78.02%
HIMS financials

HIMS Forecast & Estimates

22 analysts have analysed HIMS and the average price target is 43.45 USD. This implies a price increase of 167.03% is expected in the next year compared to the current price of 16.27.

For the next year, analysts expect an EPS growth of -11.37% and a revenue growth 60.27% for HIMS


Analysts
Analysts67.27
Price Target43.45 (167.06%)
EPS Next Y-11.37%
Revenue Next Year60.27%
HIMS Analyst EstimatesHIMS Analyst Ratings

HIMS Ownership

Ownership
Inst Owners94.2%
Ins Owners5.93%
Short Float %37.45%
Short Ratio3.62
HIMS Ownership

HIMS Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
CVS CVS HEALTH CORP10.899.269B
CI THE CIGNA GROUP9.376.59B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/2794.0923.249B
LH LABCORP HOLDINGS INC15.3322.936B
DGX QUEST DIAGNOSTICS INC19.5522.859B
GH GUARDANT HEALTH INC N/A13.8B
DVA DAVITA INC11.3710.311B
BTSG BRIGHTSPRING HEALTH SERVICES28.076.936B
CHE CHEMED CORP18.436.699B
OPCH OPTION CARE HEALTH INC18.485.594B

About HIMS

Company Profile

HIMS logo image Hims & Hers Health, Inc. operates a telehealth consultation platform. The company is headquartered in San Francisco, California and currently employs 1,637 full-time employees. The company went IPO on 2019-09-09. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. The company connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. The company also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.

Company Info

HIMS & HERS HEALTH INC

2269 Chestnut St, #523

San Francisco CALIFORNIA 94123 US

CEO: Andrew Dudum

Employees: 1637

HIMS Company Website

HIMS Investor Relations

Phone: 18003166660

HIMS & HERS HEALTH INC / HIMS FAQ

What does HIMS & HERS HEALTH INC do?

Hims & Hers Health, Inc. operates a telehealth consultation platform. The company is headquartered in San Francisco, California and currently employs 1,637 full-time employees. The company went IPO on 2019-09-09. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. The company connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. The company also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.


What is the stock price of HIMS & HERS HEALTH INC today?

The current stock price of HIMS is 16.27 USD. The price decreased by -0.18% in the last trading session.


Does HIMS stock pay dividends?

HIMS does not pay a dividend.


How is the ChartMill rating for HIMS & HERS HEALTH INC?

HIMS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Can you provide the PE ratio for HIMS stock?

The PE ratio for HIMS & HERS HEALTH INC (HIMS) is 30.13. This is based on the reported non-GAAP earnings per share of 0.54 and the current share price of 16.27 USD.


Can you provide the upcoming earnings date for HIMS & HERS HEALTH INC?

HIMS & HERS HEALTH INC (HIMS) will report earnings on 2026-02-23, after the market close.